Title: Targeted Radiotherapy for Neuroblastoma with MIBG
Date: Wednesday, April 7, 2010
Time: 10:00 AM - 11:00 AM PDT
Dr. Kate Matthay, New Approaches to Neuroblastoma Therapy (NANT) Consortium leader and pediatric oncologist from the University of California - San Francisco (UCSF) presents part 2 of the ongoing NANT clinical trial series. This presentation is appropriate for parents of children with neuroblastoma, caregivers, and health care professionals. Dr. Matthay will be presenting the latest information concerning the use of MIBG in neuroblastoma therapy. She will discuss previous clinical research in MIBG and what is currently available to patients through clinical trials. You can expect to leave this meeting with a thorough understanding of MIBG treatment in neuroblastoma, the eligibility requirements, and what is currently being offered.
To register or find out more information, please visit: